Comment on "Clinicopathological and molecular analysis of cutaneous leiomyosarcoma: A retrospective multicenter study of 79 cases".

To the Editor: We thank the readers for their comments and giving us the opportunity to discuss further the outcome of cutaneous leiomyosarcoma. Comment on: “Clinicopathologic and molecular analyses of cutaneous leiomyosarcoma: A retrospective, multicenter study of 79 cases”Journal of the American Academy of DermatologyVol. 89Issue 1PreviewTo the Editor: We read with great interest Planet et al's1 study characterizing the clinicopathologic features and prognostic factors of cutaneous leiomyosarcoma. In this retrospective, multicenter study of 79 cutaneous leiomyosarcomas (defined by their criteria as confined to the dermis or involving the subcutis), the authors report recurrence in 15.2% of patients and regional or distant metastasis in 8.9% of patients included in their study. We agree with Planet et al's1 conclusion that cutaneous leiomyosarcoma overall portends a good prognosis. Full-Text PDF